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Background: Enzyme-linked immunosorbent assay (ELISA) is often used to test wildlife samples for Mycobacterium
avium subsp. paratuberculosis (MAP) infection. However, commercially available kits are only validated for use with
domestic ruminant species. A literature review was performed to document the current use of MAP serum ELISA in
wild and semi-domestic ruminants. We then modified and evaluated a commercial ELISA kit (IDEXX Mycobacterium
paratuberculosis Antibody Test Kit) for use with species for which it was not originally developed: elk (Cervus
elaphus), bison (Bison bison) and caribou (Rangifer tarandus). We tested the affinity of different conjugates for
immunoglobulin G (IgG) isolated from these species, performed checkerboard tests to determine the optimal
dilutions of samples and conjugates, and established cut-off values using two different methods: a Receiver
Operational Curve on a panel of known samples for elk, and an alternate method involving a panel of unknown
serum samples for the three species.
Results: We found that the anti-bovine conjugate included in the IDEXX ELISA kit has limited affinity for elk, bison,
and caribou IgG. Protein G showed good affinity for IgG of all three species, while anti-deer conjugate also bound
elk and caribou IgG. Using Protein G with elk serum, a cut-off sample-to-positive (S/P) value of 0.22 was selected,
resulting in a sensitivity and specificity of 73% and 90%, respectively, whereas, using an anti-deer conjugate with elk
serum, an S/P cut-off value of 0.29 gave a sensitivity of 68%, with 100% specificity. Cut-off values for bison and
caribou using the Protein G conjugate were 0.17 and 0.25 respectively.
Conclusions: Due to incomplete reporting and a lack of test validation, it is difficult to critically appraise results of
many sero-surveys that have previously been done for MAP in wildlife. Commercial ELISA kits may have limited or
no capacity to detect antibodies from species other than for which they were developed. In order to generate
reliable test results, it is essential to evaluate the test and perform modifications if deemed necessary. Despite the
challenges inherent to wildlife diagnostics, we have shown that several methods can be used to improve
confidence in test results.
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Mycobacterium avium subsp. paratuberculosis (MAP)
causes granulomatous enteritis in ruminants that can
lead to weight loss and emaciation, as well as diarrhoea
in certain species [1]. MAP has been detected in wild
ruminant species worldwide, and it is thought that all
ruminant species are susceptible to MAP infection [2].
Although clinical disease, known as Johne’s disease, has
only occasionally been described in wildlife, its impact
may be under-estimated due to incomplete knowledge
of the clinical progression of MAP infection in these
species, non-specific clinical signs, and limited testing in
these populations.
Determining the infection status of wildlife is important
to reduce the disease risks associated with translocation, to
certify infection status for importation/exportation pur-
poses, to limit sources of infection for humans and live-
stock, and to establish baseline values for future monitoring
or surveillance [3]. For the detection of current or prior
MAP infection in wild ruminants, serological methods such
as enzyme-linked immunosorbent assay (ELISA) may be
preferred over alternative methods such as faecal culture, as
ELISA is less expensive, fast and easy to perform, and
collected serum can be used to screen for other infections.
Serum ELISA kits marketed for the detection of MAP-
specific antibodies in domestic ruminant species are
generally not validated for use with sera from other spe-
cies [2]. It is unlikely that these tests give equivalent
results for other, even closely related species [3]. Inter-
species variations in test outcomes are due in part to the
specificity of certain reagents included in commercial
kits; for example, the labelled secondary antibodies or
conjugates may have varying capacity to bind immuno-
globulin G (IgG) from different species [4]. The level of
non-specific binding of serum proteins to components
of the ELISA assay may also be difficult to predict, and
can potentially result in a reduction of the signal-to-
noise ratio, which is the ratio of the optic density (OD)
of a positive control and a negative control at a given
sample and conjugate concentration [5]. Kits generally
recommend cut-off values to classify samples as ‘negative’,
‘positive’ or ‘suspect’. Cut-off values are selected based on a
set of parameters, in particular the species being tested, the
target condition (i.e. infected, infectious, clinically diseased),
and the testing objectives (e.g. demonstrating freedom from
infection, estimating population-level prevalence, etc.) [3].
When using a commercial kit for wildlife samples, changes
in these parameters need to be reflected by adapting the
cut-off values.
Guidelines for conducting a complete diagnostic valid-
ation have been thoroughly outlined [6,7], and detailed
recommendations for the design and reporting of
diagnostic evaluation studies for chronic diseases have
been developed [8]. However, it is not always possible orappropriate to undertake such a full evaluation in wildlife
studies due to time and budget constraints as well as sam-
ple availability, in particular accessing known positive and
negative controls. In these cases, certain modification and
evaluation steps may reduce the level of uncertainty in the
test results if a complete validation is impossible.
The objectives of this paper were first, to assess
current practices in testing and reporting of MAP serum
ELISA for wildlife samples, and second, to modify and
evaluate a commercial ELISA kit (IDEXX Mycobacterium
paratuberculosis Antibody Testa, hereafter referred to as
the IDEXX kit) for detecting current or prior MAP in-
fection in elk (Cervus elaphus), bison (Bison bison) and
caribou (Rangifer tarandus).
Methods
Literature review
A systematic search of peer-reviewed articles and pro-
ceedings related to the development or use of ELISA
tests in wildlife was performed. The keywords “serology”,
“ELISA”, “wildlife”, “ruminant”, “cervid”, “deer”, “elk”,
“bison”, “caribou”, “rangifer”, “diagnostic”, “paratubercu-
losis” and “Johne’s disease” were used in PubMed, ISI
Web of Knowledge, ScienceDirect, and Google Scholar
in January 2012. Papers found during the initial search
were carefully examined for additional relevant citations.
We included any papers that used MAP ELISA to test
for naturally infected animals in ruminant species other
than cattle, sheep and goats; experimental infections were
excluded. Among the papers that fit the above-mentioned
selection criteria, the following information was collected:
type of ELISA (commercial kit, in-house test, modified
test), modifications to the materials or procedure, and
reporting of cut-off values and test performance.
Conjugate affinity
In order to determine which conjugates could be appro-
priate for testing elk, bison, and caribou sera, we first
evaluated the binding affinity of the anti-bovine conju-
gate included in the IDEXX kita to purified IgG from
each species; cattle IgG were included for comparison.
Protein Gb, a recombinant bacterial protein that binds
IgG from a wide variety of species, was also tested for all
four species. A second anti-bovine conjugatec (hereafter
referred to as KPL anti-bovine) was tested against cattle
and bison, and an anti-deer conjugated against elk and
caribou as more specific alternatives.
For each species, IgG was purified from a pooled
serum sample of four individuals, using the Melon Gel
IgG Spin Purification Kit (Thermo Scientific, Pierce
Biotechnology, Rockford, Illinois, USA), following manu-
facturer’s instructions. The protein concentration of each
purified IgG product was determined using the Bradford
titration method (Bradford Reagent, Sigma-Aldrich, St.
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the four species were adjusted to a concentration of 400
μg/ml by addition of phosphate-buffered saline (PBS,
pH = 7.2). Eight two-fold serial dilutions of the purified
IgG product were made in a coating buffer (50 mM
sodium carbonate pH = 9.6), from a starting concentra-
tion of 2 μg/ml. Subsequently, 100 μl of each dilution of
purified IgG was incubated on an Immulon 4 HBX
microtitre 96-well plate (binding capacity: 400–500 ng
IgG/cm2; coefficient of variation <5%) for 2.5 hours at
37°C. Wells were washed three times with washing
buffer (Phosphate-buffered saline solution containing
0.05% Tween20, hereafter called PBS-T), and blocked
with 1% Bovine Serum Albumin (BSA) in PBS-T (300 μl
per well) for one hour at 37°C. To ensure that there was
no interaction between the conjugate and the blocking
reagent, and to verify that a 1% solution was an optimal
blocking concentration, control wells with different
concentrations of the blocking solution (0.5%, 1% and
2.5% BSA) were included on the plate.
After repeating the previous wash protocol, 100 μl of
the conjugate being tested was added to each well and
incubated for 30 minutes at room temperature. Prelim-
inary testing was conducted to determine the conjugate
concentrations that would give an optical density (OD)
of approximately 2.0 for at least one of the species being
tested in order to obtain a sufficient range of ODs allow-
ing between-species comparisons. These were deter-
mined to be 1:12000, 1:20, 1:100, 1:500 for Protein G,
IDEXX kit anti-bovine, anti-deer and KPL anti-bovine,
respectively, diluted in PBS-T 0.1% BSA (data not
shown). Following incubation with the conjugate, the
plate was washed three times, and wells were revealed
by the addition of 100 μl of Tetramethyl benzidine
(TMB) included in the IDEXX kit. The reaction was
stopped after five minutes with the “stop solution”
provided in the kit. The OD of each well was measured
using a spectrophotometer at 450 nm (Expert 96, ASYS).
We plotted the OD on the y-axis and the serial dilutions
of IgG on the x-axis, and the area under the curve
(AUC) was calculated (Excel, Microsoft Office 2010) as
an index of binding affinity for comparison between
species within each conjugate.
Optimization
A checkerboard test (CBT) was performed using Protein
G with all three species, as well as anti-deer for elk and
caribou, to find the optimal concentrations of sample
and conjugate that would provide the best signal-to-
noise ratio. Appropriate ranges of serum and conjugate
dilutions were identified by preliminary testing (data not
shown), and all combinations within these ranges were
tested with a positive and negative control sample, using
a separate microtitre plate for each. For both bison andelk, high sero-reactors (based on preliminary testing
using Protein G) were selected for use as positive con-
trols from among individuals that had tested positive for
MAP by either faecal or tissue culture. For these two
species, negative control samples were available from
farmed herds that had repeatedly tested negative by
faecal culture over several years. For caribou, it was not
possible to obtain samples from animals of known infec-
tion status; however, serum from an animal with a high
MAP antibody titre was available, and this was used as a
positive control [9]. Serum from a caribou with a low
OD on preliminary testing was selected as a negative
control in the CBT.
A 96-well microtitre plate provided in the IDEXX kit
was used for each of the positive and negative control
samples. These plates are pre-coated with MAP antigen.
Eight two-fold dilutions of the sample were plated onto
eight columns, starting at a 1:5 dilution. Samples were
diluted in the sample diluent provided in the IDEXX kit,
allowing the M. phlei adsorption step to partially remove
cross-reacting antibodies [10]. After plating the samples,
manufacturer’s instructions were followed until conju-
gate was added. At this step, eight two-fold dilutions of
the conjugate were prepared in order to include approxi-
mately four dilutions above and below the concentration
recommended by each conjugate manufacturer. Conju-
gate dilutions ranged from 1:500 to 1:64000 for Protein
G and from 1:125 to 1:4000 for anti-deer. Each conju-
gate dilution was plated onto one of the eight rows of
the assay plate. Wells containing conjugate diluted in
PBS-T 0.1% BSA instead of the conjugate diluent from
the IDEXX kit were included as a control for non-
specific binding. The final steps of the ELISA were
performed according to the manufacturer’s instruc-
tions, except for the length of revelation with the TMB
substrate when using the Protein G conjugate, which
based on visual observation was judged to be optimal
at 5.5 minutes +/− 30 seconds.
The interpretation of the checkerboard test was done
according to Crowther et al. [5]. The negative CBT was
used to find the acceptable range of conjugate dilutions
that minimized the background noise, i.e. the OD of a
negative sample. On the positive CBT, we selected the
range of conjugate dilutions that gave appropriate titra-
tion curves, i.e. the curve displayed a sigmoid shape
from the highest to the lowest sample dilution, reaching
the level of background signal. The final conjugate con-
centration was selected based on the overlap between
these two ranges. To select the sample dilution, the
binding ratio (OD positive/OD negative) was calculated
for each combination of conjugate and sample dilution.
The sample dilution was chosen to maximize this ratio,
and as a secondary criterion, minimize the amount of
serum required.
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Samples from animals of known infection status
The optimal way to establish cut-off values is to test a
panel of samples from animals of known infection status
[6]. This was possible for both elk and bison, as refer-
ence samples were available. For elk, the reference panel
consisted of 20 negative and 22 positive samples. Nega-
tive samples were from individual farmed elk that tested
negative to either faecal or tissue culture and serology
done at the Johne’s Information Center, University of
Wisconsin, Madison. These elk were from herds in
Montana, USA that had no clinical evidence of Johne’s
disease and were negative by repeated serum ELISA test-
ing over several years.e Positive samples were from indi-
viduals that tested positive by ELISA and by tissue and/
or faecal culture at this same diagnostic centre, and were
from herds with clinical cases of Johne’s disease. For
bison, the panel contained 20 negative and five positive
samples. Negative samples were from individual free-
ranging bison that were negative by faecal culture, from
herds with no evidence of infection over a five-year test-
ing period. Positive samples were from clinically affected
animals confirmed to be infected by tissue culture and
that tested positive by ELISA and agarose gel immuno-
diffusion (AGID). These control samples were tested
with the IDEXX kit using the optimal concentrations of
sample and conjugate defined in the previous step.
Protein G was tested for both species, and anti-deer was
also tested for elk. Sample-to-positive (S/P) ratios were
calculated for each sample using the IDEXX kit positive
and negative controls as the reference (S/P = [Sample-
RefNeg]/[RefPos-RefNeg]). From the results obtained
from these panels, the optimal cut-off value, sensitivity
and specificity were determined using ROC analysis,
calculated using STATA 11.2 (StataCorp, Texas, USA).
Alternative cut-off calculation
As a panel of reference samples was not available for
caribou, an alternative means for defining a cut-off was
used. This method was also used for elk and bison to
provide a comparison with the reference panel. For each
species, a bank of serum from individual animals of
unknown infection status, independent from the panel
samples, was available. Sera from adult caribou (n = 135)
were obtained from herds in western Greenland (pro-
vided by C. Cuyler of the Greenland Institute of Natural
Resources) and northern Quebec, Canada (provided by
S.D. Côté of Université Laval). These samples were col-
lected between 2008 and 2009 through the CircumArctic
Rangifer Monitoring and Assessment Network [11]. A
total of 312 serum samples from yearling and adult elk
were obtained from ten herds in western Alberta, Canada,
through capture efforts of multiple projects occurring in
the region between 2007 and 2012 (Montane Elk ResearchProject, Parks Canada, University of Alberta). Serum
samples from 130 individual adult bison were collected by
various collaborators from northern Alberta and British
Columbia, and the Northwest Territories, Canada, between
2007 and 2011. The approach used to define the cut-off
value and test performances for these samples was modified
from Desquesnes et al. 2009 [12]. Briefly, the samples were
tested according to the conditions determined in the previ-
ous steps, and S/P ratios calculated using the controls
included in the IDEXX kit (to facilitate the use and repro-
ducibility of these findings in other laboratories). Positive
and negative controls from the species being tested were
also included on each plate. The cut-off value suggested by
the kit for negative samples (S/P = 0.3) was taken as the
preliminary cut-off value for selecting presumed negative
samples. The mean S/P value from this presumed negative
pool was calculated, and a new cut-off value was defined
(Mean S/P Neg + 3 standard deviations (SD)).Results
Literature review
The literature search yielded a total of 60 papers; 29
were retained as relevant to the scope of this article
[9,13-41], four of which were proceedings. Ten papers
reported the use of in-house ELISA, 14 used commercial
kits, and one article made a comparison of an in-house
procedure and a commercial kit. It is noteworthy that in
four papers it was impossible to identify which kit or
procedure was used, and in some publications the
procedure and modifications were insufficiently docu-
mented to allow for the experimental conditions to be
reproduced. Of the studies that used commercial kits, 12
did not perform any modifications to account for testing
a different species. Overall, only five papers reported any
kind of test evaluation or referred to studies that had
done so. Eleven papers failed to discuss the cut-off value
used to distinguish between positive and negative results.
Only one paper reported the sensitivity and specificity
values of their modified test for the species for which
the test was applied [23].Conjugate affinity
The affinity of the IDEXX kit anti-bovine conjugate was
high for cow IgG (area under the curve (AUC) = 9.5),
low for elk (AUC = 2.1), and insignificant for bison and
caribou (AUC = 0.5; Figure 1). Similarly, the KPL anti-
bovine conjugate had a very high affinity for cow IgG
(AUC = 23.0) and a much lower affinity for bison IgG
(AUC = 4.7). Protein G had a comparable affinity for elk
(AUC = 5.2), caribou (AUC = 5.3) and bison (AUC = 4.6),
but a higher affinity for cow IgG (AUC = 11.4). Finally,
the anti-deer conjugate showed comparable affinity
between elk (AUC = 6.4) and caribou (AUC = 6.7). No
Figure 1 Binding affinity of Protein G and anti-bovine
conjugate for cow, elk, caribou and bison IgG, and affinity of
anti-deer conjugate for caribou and elk IgG. Dilutions are given
as fractions of an initial IgG solution at 2 μg/ml.
Pruvot et al. BMC Veterinary Research 2013, 9:5 Page 5 of 8
http://www.biomedcentral.com/1746-6148/9/5background signal was detected in any of the control
wells coated with blocking solution.
Optimization
The optimal conjugate and sample dilutions determined
for each species are presented in Table 1. No significant
difference in OD was observed between the conjugateTable 1 Checkerboard test results
Elk Caribou Bison
Protein G dilution (a) 1:16000 1:8000 1:16000
Anti-deer dilution 1:250 (b) 1:175 (c) NT
Sample dilution using Protein G 1:30 1:20 1:160
Sample dilution using anti-deer 1:30 1:5 NT
(a) Concentration not available from manufacturer.
(b) 0.40 μg/ml.
(c) 0.57 μg/ml.
Optimal dilutions of Protein G and anti-deer conjugates when used with
serum from elk, caribou or bison, and optimal species-specific serum dilutions
for use with the IDEXX Mycobacterium paratuberculosis Antibody Test. NT: not
tested.diluted in PBS-T versus the conjugate diluent provided
in the IDEXX kit, ensuring the absence of non-specific
binding between the kit conjugate diluent and the new
conjugates.
Determination of cut-off value and sensitivity/specificity
Samples from animals of known infection status
ELISA test parameters for elk serum using either the
Protein G or anti-deer conjugate are given in Table 2.
Since Protein G and anti-deer conjugates resulted in the
correct classification of a similar number of animals, and
since Protein G is more readily available to end-users,
we selected this conjugate to proceed with further test-
ing. A cut-off value could not be established using the
panel of known bison samples due to the nature of the
positive samples in the panel, which were from animals
with advanced clinical disease. These sera had very high
S/P ratios, and were unlikely representative of subclini-
cally infected animals; we would not expect animals at
earlier stages of infection to have such high antibody
concentrations. Given this biased distribution of S/P
ratios in our positive control group, we determined that
this method would result in an inappropriate cut-off for
our target population.
Alternative cut-off calculation
Of the 312 elk samples of unknown status, 308 were
presumed negative as defined by the preliminary cut-off
of S/P = 0.3. S/P ratios of the presumed negative
samples were averaged (m = 0.066, SD = 0.039) and a
new cut-off value was calculated as m + 3 SD = 0.18.
Using this method with bison sera, 129 of 130 samples
of unknown status were presumed negative with the
preliminary cut-off. After calculating the average S/P
ratio (m = 0.039) and standard deviation (SD = 0.042) of
these samples, the new cut-off was defined as 0.17.
Among 135 adult caribou serum samples, 134 samples
were presumed negative, yielding a final cut-off of 0.25
(m = 0.083, SD = 0.054).
Discussion
Literature review
We found that ELISA is commonly used for testing for
MAP infection in different wild and semi-domestic
ruminant species, but discrepancies exist in terms of the
quality of the data reported. In many of the papers we
reviewed, the methods were incompletely described,
limiting the ability of the reader to reproduce the test
conditions or to critically interpret the results of these
studies. Despite inherent challenges in wildlife diagnos-
tics, appropriate test modification and validation steps
are necessary. We have presented a range of experiments
that can be undertaken to reach this objective.
Table 2 ELISA test parameters when using protein G or anti-deer conjugates with elk serum
S/P cut-off AUC [95% CI] Se [95% CI] Sp [95% CI] PPV [95% CI] NPV [95% CI]
Protein G 0.22 0.81 [0.65; 0.91] 73% [50; 89] 90% [68; 99] 89% [65; 99] 75% [53; 90]
Anti-deer 0.29 0.85 [0.71; 0.95] 68% [45; 86] 100% [83; 100] 100% [78; 100] 74% [54; 89]
Sample-to-positive (S/P) ratio cut-off values as determined by Receiver Operational Curve (ROC) analysis, the area under the curve (AUC), and the resulting
sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV).
Pruvot et al. BMC Veterinary Research 2013, 9:5 Page 6 of 8
http://www.biomedcentral.com/1746-6148/9/5Conjugate affinity
We found that the choice of conjugate has an important
impact on the test performance due to species-associated
differences in affinity. Although it was impossible to directly
compare the binding affinity of the different conjugates due
to the inaccessibility of information about the concentra-
tion of these products (proprietary information), it was
possible to compare the affinity of each conjugate between
species. Protein G would be a suitable conjugate for IgG
from any of the three species of interest, and anti-deer is an
appropriate alternative for elk and caribou samples. The
low affinity of the IDEXX kit anti-bovine conjugate for elk,
bison and caribou immunoglobulin makes it inappropriate
for testing samples from these species.
In this study, the binding affinity of Protein G for elk
and caribou was similar, although lower than it was for
cattle; the same trend was previously shown for red deer
(Cervus elaphus) and reindeer (Rangifer tarandus) in
comparison to cattle [37]. Our results differed slightly
from those reported by Kramsky et al., who found that the
Protein G binding affinity was similar for bison and cattle,
although similarly to this study, they found that elk had a
lower binding affinity than cattle [4]. Our findings also
confirmed these authors’ observation that it is impossible
to infer binding affinity between closely related species.
Optimization
Table 1 contains the recommended sample and conju-
gate dilutions for using the IDEXX kit with elk, caribou
and bison sera. Aside from using these modified dilu-
tions and alternate conjugates, we recommend that the
protocol be followed according to the manufacturer’s
recommendations.
We observed considerable variations in test results
associated with the duration of incubation with the
Tetramethyl benzidine (TMB) substrate; it is important
that this time be kept consistent between test development
steps and sample runs. Even when keeping the incubation
time consistent, there were small differences between runs
of the panel of samples. This variability may in part be
attributed to the very low concentration of Protein G
used in our assay, as concentrations may be difficult to
reproduce exactly between tests.
Determination of cut-off value and sensitivity/specificity
It has been suggested that to establish a cut-off value
and subsequently calculate the test accuracy with a highlevel of precision, a panel of 100 positive and negative
control samples should be tested [3]. Other authors suggest
using thousands for validation prior to commercialization
[7]. Meeting these recommendations becomes even more
challenging for wildlife when selection criteria for appro-
priate control samples are considered. In an ideal scenario,
samples should reflect the target population in terms of
the age and sex ratio, the geographic location, and the
distribution of animals between different stages of infection
[42]. They should also reflect the target condition that has
been defined by the researcher; for example, the three
target conditions that are described for MAP are infected,
infectious, and affected [42].
Our panel of known-status elk samples included
animals of all three target conditions: clinically affected;
seropositive and tissue culture positive (infected); and
seropositive and faecal culture positive (infectious). This
panel is therefore compatible with our objective of
detecting infected animals regardless of their disease
stage. However, the proportion of animals in each cat-
egory may not reflect what is seen in a free-ranging
population. The high number of clinically diseased ani-
mals among the positive control elk samples in our
study likely means that we overestimate this ELISA’s
ability to detect infected animals. Due to the relatively
small number of known elk samples in our panel, our
sensitivity and specificity estimates had large confidence
intervals. The panel of known bison samples were even
less representative of the target population since all posi-
tive animals were clinically diseased, making inferences
about test sensitivity and specificity for infected animals
impossible. Another limitation of the panel of reference
samples is that an ELISA test of unknown performance
was used to confirm some of the negative control
samples. The Johne’s Information Center used an older
version of the IDEXX test that employed an anti-ruminant
conjugate as opposed to an anti-bovine conjugate.
Although we are certain that this test was capable of
detecting positive animals, the sensitivity is unknown. If
there were animals falsely classified as negative in our
panel, the result would be an underestimation of the
specificity of our modified test.
When recommended numbers of appropriate control
samples are unavailable, a cut-off value may be estab-
lished either by using a panel with fewer samples of
known status (recognizing the limited precision of the
estimates of sensitivity and specificity), or by using
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nizing that they are imperfect approximations and lack
robustness). A commonly-used alternative is to identify
and test a group of confirmed uninfected animals and to
use the mean S/P + 3 SD of this group as the cut-off [5].
In this paper, we illustrated the worst-case scenario in
which no reference samples for the species of interest
were available and a presumed negative group had to be
created. With this method, the final cut-off value is very
sensitive to variations in the initial cut-off value selected.
However in our study, the S/P cut-off values calculated
for elk using both a panel of known control samples
(0.22) and this alternative method (0.18) were quite similar.
Since this was the only method that could be used for
establishing a cut-off value for bison and caribou sera,
sensitivity and specificity estimates could not be generated
for this ELISA test for these species.
Testing objectives are important for the selection of
the cut-off value, as researchers may wish to prioritize
either a higher sensitivity or specificity. Although not
the scope of this paper, our end-goal of adapting ELISA
for these different species was to use it as a screening
method to identify individual animals that are more
likely to be infected. This would be confirmed using
more specific MAP diagnostic methods such as faecal
culture. Based on this objective, we wanted to select a
cut-off that would optimize both sensitivity and specifi-
city and give the highest percentage of correctly classi-
fied samples. If this test were to be used as a more
definitive diagnostic test, for example in a test-and-cull
strategy, the cut-off for a “positive result” needs to be
selected to give a very high specificity. Using the ROC
curve from our panel of elk samples using the Protein G
conjugate, the cut-off value that gave 100% specificity
was 0.5. The range of S/P values between our screening
cut-off and this cut-off for positive samples could be
designated as “suspect” results (0.2 to 0.5). Alternatively,
the anti-deer conjugate could be selected over Protein G
at the recommended dilution if the test objectives
required a higher specificity.
Conclusions
In conclusion, despite the abundant literature that exists
on test development and validation, diagnostic tests
validated only for livestock species are frequently applied
for wildlife samples. As we illustrated, unmodified com-
mercial tests may fail to detect the immunoglobulins of
other species. From a wildlife management perspective,
this can have serious implications for epidemiological
surveillance. In this study we adapted a commercial
ELISA kit for use with other species: we evaluated the
binding affinity of different conjugates to IgG of the tar-
get species, ensured the absence of non-specific binding
after modifications, performed a checkerboard test torecommend optimal sample and conjugate dilutions,
and determined appropriate cut-off values. Such modifi-
cation and evaluation steps enable valuable data to be
generated from serological surveys for MAP in wildlife
that can be critically appraised and interpreted with
greater confidence.
Endnotes
aIDEXX Mycobacterium paratuberculosis Antibody
Test, Westbrook, Maine, USA; manufactured by Institut
Pourquier, Montpellier, France.
bHRP-recombinant-Protein G, Invitrogen, Camarillo,
California, USA.
cPeroxidase-Labeled Antibody to Bovine IgG, Kirkegaard
& Perry Laboratories (KPL) Inc., Gaithersburg, Maryland,
USA.
dPeroxidase-Labeled Affinity Purified Antibody to
Deer IgG, KPL Inc.
eThe Johne’s Information Center used the IDEXX
MAP ELISA kit manufactured in 2006 (different version
than a.).
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